CN102836354A - Medicament for treating depression - Google Patents

Medicament for treating depression Download PDF

Info

Publication number
CN102836354A
CN102836354A CN2012103473188A CN201210347318A CN102836354A CN 102836354 A CN102836354 A CN 102836354A CN 2012103473188 A CN2012103473188 A CN 2012103473188A CN 201210347318 A CN201210347318 A CN 201210347318A CN 102836354 A CN102836354 A CN 102836354A
Authority
CN
China
Prior art keywords
parts
depression
medicament
treating
herba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012103473188A
Other languages
Chinese (zh)
Other versions
CN102836354B (en
Inventor
史继红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Neolith Basalt Fiber Co., Ltd.
Original Assignee
史继红
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 史继红 filed Critical 史继红
Priority to CN 201210347318 priority Critical patent/CN102836354B/en
Publication of CN102836354A publication Critical patent/CN102836354A/en
Application granted granted Critical
Publication of CN102836354B publication Critical patent/CN102836354B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a medicament for treating depression, which is prepared by the following bulk drugs calculated according to parts by weight: 10 parts of indigo naturalis, 15 parts of plant soot, 15 parts of licorice, 20 parts of nutgall, 10 parts of rhizoma atractylodis macrocephalae, 10 parts of discolorous clinquefoil root, 5 parts of lithospermum, 15 parts of Japanese ardisia herb, 15 parts of pueraria flower, 10 parts of lophatherum gracile, 15 parts of pokeberry root and 10 parts of euphorbia lunulata. According to the medicament for treating the depression, which is disclosed by the invention, natural medicines are used. The medicament for treating the depression is quick to act, has a good curative effect and is very suitable for treating the depression in modern mental diseases.

Description

A kind of medicament of treating depression
Technical field
The present invention relates to mental illness treatment field, specifically, relate to a kind of medicament of treating depression.
Background technology
Depression belongs to a kind of common type in the mood disorders on classification of diseases.Chinese and western medicine theory all has more deep understanding to it, in treatment, also differs from one another.
At present, the needs for the medicine of treating depression constantly strengthen.
Summary of the invention
The purpose of this invention is to provide a kind of medicament of treating depression.
In order to realize the object of the invention; The present invention provides a kind of medicament of treating depression, and it is to be processed by weight by following bulk drugs: 10 parts of 10 parts of Indigo Naturaliss, 15 parts of Pulvis Fumi Carbonisatuss, 15 parts in Radix Glycyrrhizae, 20 parts of Galla Chinensiss, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Herba Potentillae Discoloris, 5 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Herba Ardisiae Japonicaes, 15 parts of Flos puerariae lobataes, 10 parts of Herba Lophatheris, 15 parts of Radix Phytolaccaes and Herba euphorbiae lunulataes.
Preferably, said medicament is tablet, capsule, decoction, powder or granule.
The medicament of treatment depression of the present invention uses natural drug, and its instant effect, good effect are very suitable for treating the depression in the modern mental illness.
The specific embodiment
Below description through the specific embodiment the present invention is described further; But this is not to be limitation of the present invention; Those skilled in the art are according to basic thought of the present invention; Can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within scope of the present invention.
The preparation of embodiment 1 powder of the present invention
Get Indigo Naturalis 100 grams, Pulvis Fumi Carbonisatus 150 grams, Radix Glycyrrhizae 150 grams, Galla Chinensis 200 grams, the Rhizoma Atractylodis Macrocephalae 100 grams, Herba Potentillae Discoloris 100 grams, Radix Arnebiae (Radix Lithospermi) 50 grams, Herba Ardisiae Japonicae 150 grams, Flos puerariae lobatae 150 grams, Herba Lophatheri 100 grams, Radix Phytolaccae 150 grams and Herba euphorbiae lunulatae 100 grams; Pulverize; Cross 100 mesh sieves; Add lactose 100 gram then and restrain with Icing Sugar 200, mixing, packing into promptly gets in 100 bags.
Experimental example
In following clinical case, only will meet " Chinese mental disorder classification schemes and diagnostic criteria " third edition (CCMD-3) and classify the clinical observation object as about the case of above-mentioned paralepsy diagnostic criteria.
Choose 176 routine patients with depression, wherein, mild depression 16 examples, characteristic of disease depression 76 examples that are a cup too low, depressed 17 examples of spiritedness characteristic of disease, recurrent major depression 67 examples.Man 79 examples, women 97 examples, the age between 17~72 years old, 37 years old mean age.The course of disease is February to 11 year.All patients all give psychological test and comprise Self-reporting inventory (SCL-90), self rating depressive scale (SDS).According to Chinese norm result explanation, slight depressed (SDS measures and divides 53~62 standard branches) 26 people, moderate depression (SDS measures and divides 63~72 standard branches) 71 people, severe depression (SDS measures and divides more than the 72 standards branch) 79 people.
Use the powder that makes among the embodiment 1 to treat, wherein one day 2 times, each one bag, treating March is a course of treatment.
Curative effect determinate standard
Produce effects: 9 clinical symptoms in the CCMD-3 diagnostic criteria all disappear, and patient's self assessment satisfaction rises, and it is normal that social life adapts to situation, and the SDS scoring is reduced to below the cut off value (53 standard branch); Effectively: clinical symptom relief, patient's self assessment satisfaction rise, and social life adaptation situation is improved, and the SDS decline of marking transfers the moderate depression to by severe depression, transfers slight depression to by the moderate depression.Invalid: clinical symptoms, patient's self assessment satisfaction, social life adapt to situation, the SDS scoring does not all have obviously improvement.
Therapeutic outcome
Above-mentioned case through the treatment after, produce effects 106 examples (60.2%), effective 54 examples (30.1%), invalid 16 examples (9.1%), total effective rate 90.9%.Serious adverse reaction does not all appear in above case in the therapeutic process.

Claims (1)

1. medicament of treating depression; It is characterized in that it is to be processed by weight by following bulk drugs: 10 parts of 10 parts of Indigo Naturaliss, 15 parts of Pulvis Fumi Carbonisatuss, 15 parts in Radix Glycyrrhizae, 20 parts of Galla Chinensiss, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Herba Potentillae Discoloris, 5 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Herba Ardisiae Japonicaes, 15 parts of Flos puerariae lobataes, 10 parts of Herba Lophatheris, 15 parts of Radix Phytolaccaes and Herba euphorbiae lunulataes.
CN 201210347318 2012-09-19 2012-09-19 Medicament for treating depression Expired - Fee Related CN102836354B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210347318 CN102836354B (en) 2012-09-19 2012-09-19 Medicament for treating depression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210347318 CN102836354B (en) 2012-09-19 2012-09-19 Medicament for treating depression

Publications (2)

Publication Number Publication Date
CN102836354A true CN102836354A (en) 2012-12-26
CN102836354B CN102836354B (en) 2013-09-18

Family

ID=47364257

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210347318 Expired - Fee Related CN102836354B (en) 2012-09-19 2012-09-19 Medicament for treating depression

Country Status (1)

Country Link
CN (1) CN102836354B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107224527A (en) * 2017-07-31 2017-10-03 南阳市中心医院 Prevent and treat Chinese medicine composition of percutaneous transluminal coronary stent implantation infectious-related complication and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1186687A (en) * 1997-10-06 1998-07-08 陈创 Cancer preventing curing medicine series and its preparation
CN1276216A (en) * 2000-05-25 2000-12-13 赵国林 Process for preparing non-decoction Chinese medicine
CN102106994A (en) * 2009-12-28 2011-06-29 曹斌 Treatment formula for epilepsies and manufacturing method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1186687A (en) * 1997-10-06 1998-07-08 陈创 Cancer preventing curing medicine series and its preparation
CN1276216A (en) * 2000-05-25 2000-12-13 赵国林 Process for preparing non-decoction Chinese medicine
CN102106994A (en) * 2009-12-28 2011-06-29 曹斌 Treatment formula for epilepsies and manufacturing method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
李峰: "抑郁症的中医治疗", 《福建中医药》 *
翁黄念慈等: "中药复方治疗抑郁状态的述评", 《四川中医》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107224527A (en) * 2017-07-31 2017-10-03 南阳市中心医院 Prevent and treat Chinese medicine composition of percutaneous transluminal coronary stent implantation infectious-related complication and preparation method thereof

Also Published As

Publication number Publication date
CN102836354B (en) 2013-09-18

Similar Documents

Publication Publication Date Title
CN101711810B (en) Preparation used for improving sleep and enhancing immunity
CN102764340A (en) Traditional Chinese medicine composite capable of improving sleep and preparation method and application thereof
CN101816771B (en) Chinese medicinal composition for treating epilepsy disease and preparation method thereof
CN102727706A (en) Composition for preventing and treating diabetes
CN102302654B (en) Medicinal liquor for effectively treating insomnia
CN114224998A (en) Traditional Chinese medicine composition for treating spleen-kidney yang deficiency type functional dyspepsia, preparation and application
CN101810787A (en) Chinese medicinal composition for treating dysphoria and preparation method thereof
CN106806853A (en) It is a kind of to alleviate physical fatigue and/or improve Chinese medicine composition, its preparation method and the application of anoxia endurance
KR101987418B1 (en) A composition comprising herbal mixture extract for neuroprotection
CN104225425A (en) Chinese herbal preparation for enhancing immunity, improving sleep and preventing cardio-cerebrovascular disease, and preparation method thereof
CN102836354B (en) Medicament for treating depression
CN102743645B (en) Chinese medicinal preparation for treating premature ejaculation
CN101411770B (en) Medicament for treating blood stasis accumulation type multiple sclerosis symptoms
CN103550477B (en) Medicament for treating herpes zoster
CN103285192A (en) Traditional Chinese medicine preparation for treating epilepsy
CN103495014B (en) Medicament for treating depression in psychiatric nursing
CN102302719B (en) Medicament for treating tumor
CN102228548A (en) Diet pills
CN104623382A (en) Traditional Chinese medicine for treating insomnia caused by internal disturbance due to phlegm heat
CN102205044B (en) Medicament for treating cough
CN102114149B (en) Chinese medicine preparation for treating epilepsy
CN104547851B (en) One treats hypertensive medicine
CN102793907A (en) Medicament for treating oral ulcer (decay) and preparation method thereof
CN102416147B (en) Medicinal composition for treating mania of patients abstained from drugs
CN101829213B (en) Medicine composition for treating asthma and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: JIANGSU XIN NEOLITHIC BASALT FIBER CO., LTD.

Free format text: FORMER OWNER: SHI JIHONG

Effective date: 20131202

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 272100 JINING, SHANDONG PROVINCE TO: 213399 CHANGZHOU, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20131202

Address after: 213399 Jiangsu city of Changzhou province Liyang Liyang Town of Wuhu Shanghai Road No. 168

Patentee after: Jiangsu Neolith Basalt Fiber Co., Ltd.

Address before: 272100 psychological clinic of the first people's Hospital, 6 health Road, Shandong, Jining

Patentee before: Shi Jihong

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130918

Termination date: 20150919

EXPY Termination of patent right or utility model